Showing results (1-10 of 29) with videos related to
Sort By:
Pageof 3
Hospital Medicine (London, England : 1998)|December 31, 2004
The broadening use of leflunomide in clinical practicePatrick D W KielyRheumatology (Oxford, England)|October 2, 2015
Biologic efficacy optimization--a step towards personalized medicinePatrick D W KielyCurrent Rheumatology Reports|July 27, 2013
Interstitial lung disease in inflammatory myopathies: clinical phenotypes and prognosisPatrick D W Kiely, Felix ChuaRheumatology (Oxford, England)|October 24, 2020
Ankle arthritis - an important signpost in rheumatologic practicePatrick D W Kiely, Mark E LloydRheumatology International|January 10, 2022
Rituximab and intravenous immunoglobulin treatment in PM/Scl antibody-associated disease: case-based reviewDenesh Srikantharajah, Mark E Lloyd, Patrick D W KielyThe Journal of Rheumatology|April 1, 2005
Diagnosing hypovitaminosis D: serum measurements of calcium, phosphate, and alkaline phosphatase are unreliable, even in the presence of secondary hyperparathyroidismG Richard Smith, Paul O Collinson, Patrick D W KielyInternational Journal of Rheumatic Diseases|October 28, 2016
Medical arthroscopy: A tool for diagnosis and research in rheumatologyVed Chaturvedi, Molly Mary Thabah, Vinod Ravindran, et al.Rheumatology International|August 16, 2021
Large joints are progressively involved in rheumatoid arthritis irrespective of rheumatoid factor status-results from the early rheumatoid arthritis studySizheng Steven Zhao, Elena Nikiphorou, Adam Young, et al.Rheumatology (Oxford, England)|November 1, 2011
Biologic agents for rheumatoid arthritis--negotiating the NICE technology appraisalsPatrick D W Kiely, Chris Deighton, Josh Dixey, et al.The Journal of Applied Laboratory Medicine|June 18, 2022
The Utility of Myositis Specific Antibodies in Clinical PracticeKathryn Biddle, Matthew D Taylor, Sarah E Linstead, et al.Pageof 3